Redeye states that the Q2 report was very strong as it beat Redeye's estimates on both revenue and p...
Redeye states that the Q2 report was weaker than expected in terms of sales and gross margin, but th...
Cibus's Q2 2022 income from property management (IFPM) was below consensus even when adjusting for E...
-14% return in Q2… …driven by +5% in NAV and +16pp in discount NAV discount currently at 25% (histor...
Remarkable order intake 35% better than ABGSCe ‘23e EBIT up 8% and ‘24e up 4% Fair value range of ...
Q2: better sales and gross profit, but shortfall on EBIT We cut ‘23e EBIT by 20% on lower GMs and hi...
Redeye retains its positive view on Sdiptech following a Q2 report beating our forecasts with 5%.
Redeye gives a short comment on today’s news and reiterate our view of Nanexa.
Vi ser pressen på Mobile som tillfällig Kinas nolltolerans mot COVID-19 orsakade att mobilförsäljnin...
Nimbus har lyckats bra med att parera för kostnadsökningar och orderboken är välfylld.
SRV's net sales in Q2 amounted to EUR 211.4m, above our estimates and in line with consensus (EUR 19...
Innofactor’s Q2 results were weaker than expected. Net sales declined 2% y/y to EUR 16.
Sales +36% y-o-y, +12% vs. ABGSCe Gross margin pressure continues Cons.
Redeye expects to mute sales expectations slightly since customer delays have impacted these.
Redeye states that last night's capital raise was well needed.
Redeye retains its positive view on Sdiptech following a Q2 report beating our forecasts by 5%, main...
Redeye states that the Q2 report came in somewhat lower than estimates in terms of sales, but that t...
Redeye comments on Stillfront’s Q2-results which came in close to our expectations and while organic...
We expect soft Q2 results on 17 August. While we expect sales to increase by 7% (-17% organic), lif...
Redeye retains its positive view towards Efecte following an H1 report in line with our expectations...
